India, Sept. 13 -- Molbio Diagnostics is primarily a diagnostics technology company, with molecular diagnostics forming the core of its business. Its main platform, Truenat, is designed to bring molecular testing closer to the point of care, reducing the need to depend on central laboratories. The company therefore operates differently from diagnostic laboratory chains, focusing instead on developing the devices and consumables used to perform molecular tests.

The company has also delivered strong growth in its core business, but its shares trade at a premium valuation compared with the broader diagnostics industry. Understanding how Truenat works, how Molbio makes money from its platform, what differentiates it from other diagnostics pr...